journal article·2020-01-01Open access

Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery

Beatriz Garcia-Pinel, Alicia Ortega-Rodríguez, Cristina Porras-Alcalá, Laura Cabeza, Rafael Contreras-Cáceres, Raul Ortiz, Amelia Díaz, Ana Moscoso, Francisco Sarabia, José Prados, Juan M. López-Romero, Consolación Melguizo

Abstract

Here, temperature-sensitive hybrid poly(N-isopropylacrylamide) (pNIPAM) nanosystems with magnetic response are synthesised and investigated for controlled release of 5-fluorouracil (5FU) and oxaliplatin (OXA). Initially, magnetic nanoparticles (@Fe3O4) are synthesised by co-precipitation approach and functionalised with acrylic acid (AA), 3-butenoic acid (3BA) or allylamine (AL) as comonomers. The thermo-responsive polymer is grown by free radical polymerisation using N-isopropylacrylamide (NIPAM) as monomer, N,N’-methylenbisacrylamide (BIS) as cross-linker, and 2,2’-azobis(2-methylpropionamidene) (V50) as initiator. We evaluate particle morphology by transmission electron microscopy (TEM) and particle size and surface charge by dynamic light scattering (DLS) and Z-potential (ZP) measurements. These magnetically active pNIPAM@ nanoformulations are loaded with 5-fluorouracil (5FU) and oxaliplatin (OXA) to determine loading efficiency, drug content and release as well as the cytotoxicity against T-84 colon cancer cells. Our results show high biocompatibility of pNIPAM nanoformulations using human blood cells and cultured cells. Interestingly, the pNIPAM@Fe3O4-3BA + 5FU nanoformulation significantly reduces the growth of T-84 cells (57% relative inhibition of proliferation). Indeed, pNIPAM-co-AL@Fe3O4-AA nanosystems produce a slight migration of HCT15 cells in suspension in the presence of an external magnetic field. Therefore, the obtained hybrid nanoparticles can be applied as a promising biocompatible nanoplatform for the delivery of 5FU and OXA in the improvement of colon cancer treatments.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Hydrogels: synthesis, properties, applications · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada

Department of Anatomy and Embriology, Faculty of Medicine, University of Granada

Instituto de Investigación Biosanitaria ibs.GRANADA

Department of Organic Chemistry, Faculty of Sciences, University of Málaga

Department of Chemistry in Pharmaceutical Science, Faculty of Pharmacy, Complutense University of Madrid

Funding

MINECO · Atracción de Talento fellowship · Comunidad de Madrid · Consejería de Salud de la Junta de Andalucía · Instituto de Salud Carlos III · FPU2016 · Ministerio de Educación, Ciencia y Deporte y Competitividad

References (46)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. NCBI. Colon Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf [Internet]. 2019. [cited 2019 Apr 29]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK65858
3. 10.3390/ijms1801019710.3390/ijms18010197 ↗
4. 10.4103/2319-4170.13092310.4103/2319-4170.130923 ↗
5. 10.3390/molecules1308155110.3390/molecules13081551 ↗
6. 10.1056/NEJMoa03270910.1056/NEJMoa032709 ↗
7. 10.1007/s00280-015-2901-x10.1007/s00280-015-2901-x ↗
8. 10.1016/j.phrs.2004.01.00610.1016/j.phrs.2004.01.006 ↗
9. 10.1016/j.jpainsymman.2017.07.03310.1016/j.jpainsymman.2017.07.033 ↗
10. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
11. 10.1016/0079-6700(92)90023-R10.1016/0079-6700(92)90023-R ↗
12. 10.1021/ma00008a06710.1021/ma00008a067 ↗
13. 10.1103/PhysRevLett.45.163610.1103/PhysRevLett.45.1636 ↗
14. 10.1006/jcis.1993.107510.1006/jcis.1993.1075 ↗
15. 10.1038/346345a010.1038/346345a0 ↗
16. 10.1016/j.colsurfb.2013.10.01510.1016/j.colsurfb.2013.10.015 ↗
17. 10.3390/polym303110710.3390/polym3031107 ↗
18. 10.3390/polym1002013710.3390/polym10020137 ↗
19. 10.1007/s10965-018-1453-210.1007/s10965-018-1453-2 ↗
20. 10.1016/j.biomaterials.2013.07.09210.1016/j.biomaterials.2013.07.092 ↗
21. 10.5530/ijper.52.1.710.5530/ijper.52.1.7 ↗
22. 10.1002/chem.20100126110.1002/chem.201001261 ↗
23. 10.1021/la200266e10.1021/la200266e ↗
24. 10.1021/la201723a10.1021/la201723a ↗
25. 10.1021/acsnano.5b0408310.1021/acsnano.5b04083 ↗
26. 10.1016/j.addr.2006.09.02010.1016/j.addr.2006.09.020 ↗
27. 10.1021/acsomega.7b0036710.1021/acsomega.7b00367 ↗
28. 10.1016/j.ijbiomac.2013.08.04110.1016/j.ijbiomac.2013.08.041 ↗
29. 10.1016/j.colsurfb.2017.03.01910.1016/j.colsurfb.2017.03.019 ↗
30. 10.1038/srep4109010.1038/srep41090 ↗
31. 10.1021/acsami.6b0977210.1021/acsami.6b09772 ↗
32. 10.1039/C5RA27839B10.1039/C5RA27839B ↗
33. 10.1166/jnn.2012.427510.1166/jnn.2012.4275 ↗
34. 10.1517/17425247.2012.70984510.1517/17425247.2012.709845 ↗
35. 10.1208/s12248-015-9761-510.1208/s12248-015-9761-5 ↗
36. 10.1016/j.phrs.2019.01.01310.1016/j.phrs.2019.01.013 ↗
37. Flory P. Principles of polymer chemistry. vol. 1. Ithaca (NY): Cornell University Press; 1953.
38. 10.1021/acsami.7b0820910.1021/acsami.7b08209 ↗
39. 10.1080/21691401.2017.134977710.1080/21691401.2017.1349777 ↗
40. 10.1038/boneres.2017.5110.1038/boneres.2017.51 ↗
41. 10.1172/JCI11238110.1172/JCI112381 ↗
42. 10.2147/IJN.S1216210.2147/IJN.S12162 ↗
43. 10.2147/IJN.S1617610.2147/IJN.S16176 ↗
44. 10.1021/acsomega.7b0101610.1021/acsomega.7b01016 ↗
45. 10.1039/C4NR01030B10.1039/C4NR01030B ↗
46. 10.1021/acs.molpharmaceut.8b0107310.1021/acs.molpharmaceut.8b01073 ↗